4A5.F 18.1 (+0.33%)
BE0003874915Drug ManufacturersDrug Manufacturers - Specialty & Generic

Fagron (4A5.F) Stock Highlights

18.1 | +0.33%
2024-12-21 04:01:01
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies which are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Fagron North America, Fagron South America and HL Technology.

Statistics

Range Today
18.1 18.1
Volume Today 1.2K
Range 1 Year
16.52 19.26
Volume 1 Year 4.18K
Range 3 Year
10.98 19.26
Volume 3 Year 23.67K
Range 10 Year
3.6755 40.7247
Volume 10 Year 159.51K

Highlights

Market Capitalization 1.47B (small)
Floating Shares 64.8M
Current Price 18.1
Price To Earnings 17.53
Price To Revenue 2.01
Price To Book 2.89
Earnings Per Share 1.07
Dividend Yield 1.61%
Dividend Per Share 0.3
Payout Ratio 28.04%

Performance

Latest +0.33%
1 Month -0.11%
3 Months -2.79%
6 Months +2.38%
1 Year +9.56%
3 Years +30.87%
5 Years -3.98%
10 Years -40.48%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.